As Humira biosimilars have taken over the market, CVS Caremark has created a new ploy to make money: the drug "rebate credit.
Investors are looking to build out a parallel ecosystem of startups focused on AI governance, data security and privacy, and ...
Contineum Therapeutics has filed a $150 million IPO — adding to the growing list of biotechs with plans to go public this ...
Since the 1990s, the research has been clear: Being exposed to chronic stress, both in utero and early childhood, puts kids ...
I was wrong about Geron. For years, I’ve believed — and declared publicly — that Geron’s effort to develop a blood cancer drug called imetelstat would end in disappointment. The drug was never getting ...
WASHINGTON — Most of the Supreme Court’s justices on Monday seemed to question states’ arguments that the Biden ...
The Food and Drug Administration on Monday approved a gene therapy for metachromatic leukodystrophy, a devastating genetic disorder that eats away at affected children’s neurons. The medicine, ...
Around this time three years ago, while most of us navigated pandemic life, real estate developers across Greater Boston ...
Ethylene oxide used to sterilize devices that can’t be exposed to steam, but long-term exposure linked to cancer. Vaporized ...
John Green on a new private-public partnership: "I really hope that this project can be a beacon and a blueprint for how we ...
Advocates want NIH to create an office to pursue research and treatment of long Covid, ME/CFS, Lyme disease, Ehler-Danlos ...
A top HHS official, Micky Tripathi is equal parts excited — and deeply concerned — about the technological change sweeping ...